Gilead Sciences, Inc. is a research-based biopharmaceutical company that discovers, develops and commercializes innovative medicines in areas of unmet medical need. We strive to transform and simplify care for people with life-threatening illnesses around the world. Gilead's portfolio of products and pipeline of investigational drugs includes treatments for HIV/AIDS, liver diseases, cancer and inflammation, and serious respiratory and cardiovascular conditions. - See more at: http://www.gilead.com/about#sthash.rpDd6mCW.dpuf

Research Grants show all

NIH11

Patents show all

Gilead has 3 licensable patents.
4,249Applications2,766Issued

Clinical Trials show all

202Phase 2181Phase 3111Phase 496Phase 158N/A41Other

SEC Filings show all

8-K20910-Q6710-K18D1

Contact Information


    SEC Form D Funding Events

    DateOfferedSoldType
    2006-04-03UnknownUnknownOther (Paper Filing)